| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |